|Bid||69.55 x 1100|
|Ask||69.55 x 1300|
|Day's Range||68.60 - 69.64|
|52 Week Range||59.07 - 83.89|
|PE Ratio (TTM)||16.38|
|Earnings Date||Oct 23, 2018 - Oct 29, 2018|
|Forward Dividend & Yield||1.76 (2.65%)|
|1y Target Est||71.05|
HSN, once known as the Home Shopping Network, is getting an image makeover. A U.S. television network where shoppers can buy everything from electronics to kitchen gadgets, HSN is overhauling its lineup to offer more beauty products while adding streamed video content to win over shoppers without cable TV. A division of Qurate Retail Group, the network is facing growing competition from Amazon Inc. and Evine Live Inc for consumers like 24-year old Erin Bounds, who regard buying products through TV shows a relic of the past.
U.S. stocks today ended solidly higher as the financial crisis in Turkey moved the back burner, at least for a day. IShares MSCI Turkey jumped 11% after two days of sharp losses.
Google stock Alphabet set up a new buy point. Tech, retail, health care and banking stocks gave the major indexes nice gains in afternoon trading. Chinese ADRs fell.
The rating was placed on review for possible downgrade due to the Rite Aid Corporation ("Rite-Aid") senior unsecured rating being placed on review for possible downgrade by Moody's on August 9, 2018. Rite-Aid was placed on review for possible downgrade due to Rite-Aid's announcement that it has terminated its merger agreement with Albertsons Companies, Inc. The merger termination leaves Rite-Aid in a weaker position as it lacks the scale or the balance sheet to compete in the changing pharmacy landscape with much larger and well capitalized competitors like CVS Health and Walgreens Boots Alliance, Inc. The ratings of Credit Tenant Lease (CTL) deals are primarily based on the senior unsecured debt rating (or the corporate family rating) of the tenants leasing the real estate collateral supporting the bonds.
CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors. The company’s share price soared 6% during the day on August 8 before finally settling at $68.17, 4.2% higher than the previous day’s close.
As discussed in the previous section, six analysts have downgraded Walgreens Boots Alliance (WBA) since Amazon’s (AMZN) acquisition of PillPack in late June. As a result, Walgreens’s overall ratings have come down drastically. The company, which was rated 2.3 before the acquisition on June 28, is now ranked as a 2.7. Ratings are on a scale where one is a “strong buy,” and five is a “strong sell.”
proposed merger with Albertsons Companies, the stock price for the drug-store chain dropped 11.5% to $1.54 per share in Thursday trading. Some of the happiest people about the failed deal are its shareholders. Steve Krol, who owns 260,000 Rite Aid shares, was instrumental in making sure the deal fell apart.
Moody's Investors Service ("Moody's") today placed the ratings of Rite Aid Corporation (Rite-Aid) on review for downgrade including its Corporate Family Rating of B2 and its Probability of Default Rating of B2-PD. The review for downgrade is prompted by Rite-Aid's announcement that it has terminated its merger agreement with Albertsons Companies, Inc.
Rite Aid had a horrid week. The stock has been pummeled by a spate of bad news, raising questions about how Rite Aid will continue to stack up against its competitors on pricing, footprint and innovation edge. The slide thus far was punctuated by a collapse of a merger agreement with Albertsons Cos. grocery chain, sinking the shares over 9% on Thursday to $1.58 per share.
Rite Aid notes that the reason it is no longer moving forward with the merger is due to the views of its shareholders. Rite Aid also points out that the agreement between it and Albertsons doesn’t require a payment from either company for the cancellation of the merger agreement. “We will continue building momentum for key areas of our business like our innovative Wellness store format, highly successful customer loyalty program and expanded pharmacy service offerings, as we also enhance our omni-channel and own brand offerings to strengthen our competitive position and create long-term value for stockholders,” Rite Aid Chairman and CEO John Standley said in a statement.
Amazon’s (AMZN) acquisition of PillPack and the fears of rising competition resulted in a series of Wall Street downgrades of Walgreens Boots Alliance (WBA). Three analysts downgraded their ratings on the drug store giant in June, and another three downgraded the stock in July.
CVS Health (CVS) reported its second-quarter earnings results on August 8. The pharmacy giant reported better-than-expected top and bottom line results during the quarter.
Learn about the top five major direct shareholders of Rite Aid Corporation, and learn about these shareholders' positions in Rite Aid and their backgrounds.
Walgreens Boots Alliance (WBA) stock has been in the red almost throughout the whole year so far. Interestingly, the pharmacy giant’s stock performance hasn’t been driven by its own financial performance, but by Amazon’s expansion plans in the pharma space. Walgreens has reported quarterly results for the first three fiscal quarters of 2018 this year.
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Booking Holdings Inc (NASDAQ: BKNG ) stock was trading ...
Walgreens Boots Alliance (WBA), America’s second-largest pharmacy chain and a recent addition to the Dow Jones Index, has been going strong for years. The company has grown its top line at a CAGR (compound annual growth rate) of 11% over the last five years. While the company has taken the organic as well as the inorganic route to boost sales, earnings growth has been a result of improving profitability and a solid stock repurchase plan.
Rite Aid Corp. ( RAD) and Albertsons have agreed to call off their multibillion-dollar merger after failing to convince investors that joining forces would leave them better equipped to tackle growing competition from Amazon.com Inc. ( AMZN) and others. “While we believed in the merits of the combination with Albertsons, we have heard the views expressed by our stockholders and are committed to moving forward and executing our strategic plan as a stand-alone company,” said Rite Aid’s CEO John T. Standley in a statement. Rite Aid’s shares have fallen about 22% since Albertsons' offer was first announced in February, reflecting concerns that the grocery firm’s bid undervalued the drugstore chain.
Short interest is low for WBA with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding WBA is favorable, with net inflows of $20.49 billion.
The drugstore chain plans to make video visits available nationwide by the end of the year through a partnership with Teladoc Health. CVS already offers virtual appointments, branded as MinuteClinic Video Visits, in nine states and the District of Columbia.
Court documents give some insight into one of the biggest questions about Theranos: How could its board stand pat as key employees left and allegations emerged about the blood testing company's technology?
Shares of Amazon (AMZN) popped Tuesday after D.A. Davidson analysts suggested that the next logical industries for the e-commerce giant to enter would be gas stations and travel. Amazon could likely jump into the gas station market without much fuss, similar to Costco (COST), and certainly has the online infrastructure and customer base to offer travel deals. But what should investors make of this?
Private-equity firm Advent International has held talks with potential buyers about selling pharmacy company Genoa Healthcare, according to people familiar with the matter. Genoa, which could be worth about $2.5 billion in a sale, has attracted interest from drugstore chain Walgreens Boots Alliance Inc., among other suitors, said the people, who asked not to be identified because the details aren’t public. Genoa operates more than 400 full-service pharmacies within community mental-health centers in the U.S., and serves about 650,000 customers, according to a company fact sheet.